#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrous dysplasia of bone Mitochondrial encephalomyopathy Non-small cell lung cancer recurrent Congenital hypotransferrinaemia Congenital growth hormone deficiency Thromboangiitis obliterans Anti-myelin-associated glycoprotein associated polyneuropathy Trigeminal neuralgia Prophylaxis against transplant rejection Solitary fibrous tumour Behcet's syndrome Squamous cell carcinoma of the oral cavity Polymyositis Small cell lung cancer Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Basic Information Malignant fibrous histiocytoma – Life with Disease Haemophilia Carcinoid syndrome – Trials in Disease Fragile X syndrome – Life with Disease Osteosarcoma – Basic Information Metachromatic leukodystrophy Glycogen storage disease type I Mantle cell lymphoma stage II Nephroblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bulevirtide Relacorilant Vsf1.01 O15-Water Arachis Hypogaea Flour Cocarboxylase Tetrahydrate Oxytocin Enalapril Maleate Azd5492 Gsk4381562A Magnesium Chloride Hexahydrate Dornase Alfa Cefalexin Monohydrate Loperamide SODIUM SULFIDE NONAHYDRATE Pimecrolimus Emtricitabine Misoprostol Mycophenolate Sodium Leniolisib Phosphate More therapies…

    Learn about Your Condition

    Albuminuria Peritoneal neoplasm Osteoarthritis Growth hormone deficiency Wolfram syndrome Bacterial vaginosis Diabetic autonomic neuropathy Nasal sinus cancer Emphysema Testis cancer Multiple sclerosis relapse Raynaud's phenomenon Hypervolaemia Pouchitis Vaginal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    France

  • Study on the Safety and Effectiveness of Tacrolimus and Drug Combination for Patients with BK Polyomavirus Infection After Kidney Transplantation

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciclosporin
    • Sirolimus
    • Azathioprine
    Germany

  • Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Technetium (99Mtc)
    • Tilmanocept
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • HER2 negative breast cancer
    • Breast cancer
    Investigated Drugs:
    • Everolimus
    • Exemestane
    Hungary

  • Study on Pain Relief in Hip Replacement Surgery Using Ropivacaine and Adrenaline for Patients Undergoing Total Hip Arthroplasty

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    The Netherlands

  • Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Olaparib
    The Netherlands
Previous Page
1 … 797 798 799 800 801 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!